CanadaSUVEXX tablets (sumatriptan 85 mg / naproxen sodium 500 mg), Market Authorization DIN 02496305, Lot 0000159323, are recalled because the assay is out of specification. Check whether your product is the affected lot, consult your healthcare provider before discontinuing use, contact the recalling firm with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Retailers
Companies: ARALEZ PHARMACEUTICALS CANADA INC, 6733 Mississauga Rd, Suite 800, Mississauga, ON, L5N 6J5.
How to identify it
Product Name: SUVEXX; Market Authorization: DIN 02496305; Dosage Form: Tablet; Strength: Sumatriptan 85mg Naproxen sodium 500mg; Lot number: 0000159323
The hazard
The assay is out of specification in the affected lot.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
Where it was sold
National
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)